Ashley Fuller, MD
Obstetrics & Gynecology · Seattle, WANPI 1912100116
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,583 of the $57,001 with a category attached, or 83.5%. Astellas Pharma US Inc accounts for 96.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $31,888 and has fallen 94.5% since, to $1,768 in 2025. Among obstetrics & gynecology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $770.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$55K
- Scynexis, Inc.$1K
- Cosette Pharmaceuticals Inc.$177
- Sumitomo Pharma America, Inc.$108
- AbbVie$94
- Agile Therapeutics, Inc.$65
- plus $158 from 5 others
Across 337 payments — averaging $23,137 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$6.7M
- Mylan Inc.$401K
- Organon$377K
- Teva Pharmaceuticals USA, Inc.$117K
- GSK$98K
- Pfizer$68K
- plus $61K from 1 others
What the payments were for
- Speaking & faculty fees$47,58383%
- Travel & lodging$6,80512%
- Food & beverage$2,6135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 60 | $55,126 |
| Scynexis, Inc. | 2 | $1,273 |
| Cosette Pharmaceuticals Inc. | 1 | $177 |
| Sumitomo Pharma America, Inc. | 2 | $108 |
| AbbVie | 1 | $94 |
| Agile Therapeutics, Inc. | 2 | $65 |
| Bayer | 1 | $46 |
| GSK | 1 | $43 |
| Mayne Pharma Commercial LLC | 2 | $35 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Myovant Sciences Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,001 in reported general payments places this provider in the 95th percentile of 733 obstetrics & gynecology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 18 | $9,343 |
| Estradiol | 91 | $8,379 |
| EstringEstradiol | 15 | $8,232 |
| Estradiol (Twice Weekly)Estradiol | 27 | $4,400 |
| ProgesteroneProgesterone, Micronized | 54 | $2,292 |
| ValacyclovirValacyclovir Hcl | 22 | $1,204 |
| Clobetasol Propionate | 25 | $847 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Seattle
- Joshua PressSeattle$115K
- Katherine DebiecSeattle$31K
- Susan ReedSeattle$17K
- Ying LiuSeattle$8K
- Linda EckertSeattle$7K
- Jessie MarrsSeattle$4K
- James MillerSeattle$4K
- Dilys WalkerSeattle$4K
- Carolyn KayEdmonds$310K
- Jacob CalvertVancouver$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.